ReviewFrontiers in endocrinology2026
Could refeeding-associated gynaecomastia occur during recovery from anorexia nervosa? A hypothesis-generating review.
Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
International andrology guidance discusses refeeding after starvation as a clinical setting associated with gynaecomastia, based on reports from starvation-refeeding settings outside anorexia nervosa (AN). A targeted search of PubMed, PsycINFO, and Google Scholar, last conducted on 27 July 2026, identified no indexed reports in male patients recovering from AN. We therefore advance the testable hypothesis that transient glandular breast tissue may occasionally occur but remain unrecognised during nutritional recovery; the available evidence does not establish occurrence, prevalence, or clinical significance in AN. Five endocrine transitions provide biological plausibility: non-uniform recovery of the hypothalamic-pituitary-gonadal axis, expansion of the adipose tissue compartment in which aromatase is expressed, a transient leptin rise, possible preservation of adrenal androgen precursor availability, and recovery of insulin-like growth factor 1. Direct human data in male AN support parts of the endocrine trajectory, whereas the proposed link to breast tissue relies largely on indirect human evidence and preclinical studies. Potential under-recognition could arise from misclassification as pseudogynaecomastia, patient-side under-reporting, and follow-up that ends before later endocrine recovery; no clinical detection window has been established. We propose retrospective review, prospective surveillance extending beyond acute refeeding, targeted endocrine evaluation of confirmed glandular tissue, and multicentre studies of prevalence, risk factors, natural history, psychological effects, and treatment engagement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.